Related Experiment Video
Updated: Sep 8, 2025

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
The fourth dose: My "me-first" experience
1Assistant Professor, Department of Public Health, Faculty Of Medicine, Ankara Yıldırım Beyazıt University, and Project Manager, Research for Health in Conflict (R4HC-MENA) Programme, Department of Pediatric Oncology, Hacettepe University, Ankara, TURKEY.
Abstract:
Vaccine inequality is the biggest obstacle to curbing the Covid-19 pandemic and accelerating socio-economic recovery in the developing countries. Many people, including myself, living in developing countries, were initially inoculated with the WHO-approved vaccines unwelcome to developed countries, such as Sinovac. Presently, governments in developing countries are offering the third and fourth doses of mRNA vaccines to facilitate cross-border travel. This creates a devastating burden on ongoing Covid-19 vaccination in developing countries, increasing the injustice and inequality between the developed and developing countries. Here, I share my thoughts as a public health specialist while I was receiving the fourth dose of the Covid-19 vaccine to fulfil travel requirements.
Related Concept Videos
The Sense of Self: Reflected Self-Appraisal and Social Comparison
Self-Schemas
Deindividuation
Self-Presentation: Self-Monitoring and Self-Handicapping
The Scientific Method
The Placebo Effect

